Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
361 | 3 | ADENOVIRUS//MERKEL CELL CARCINOMA//POLYOMAVIRUS | 35836 |
818 | 2 | ONCOLYTIC VIRUS//GENE THERAPY//HUMAN GENE THERAPY | 12130 |
3956 | 1 | LENTIVIRAL VECTOR//LENTIVIRUS//EXPT HEMATOL | 1909 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | LENTIVIRAL VECTOR | authKW | 1591450 | 16% | 31% | 311 |
2 | LENTIVIRUS | authKW | 279869 | 8% | 11% | 158 |
3 | EXPT HEMATOL | address | 248592 | 8% | 9% | 160 |
4 | MOLECULAR THERAPY | journal | 211400 | 11% | 6% | 217 |
5 | U962 | address | 153646 | 1% | 85% | 11 |
6 | IMMUNODEFICIENCY | address | 123891 | 2% | 24% | 31 |
7 | GENE THERAPY | authKW | 120861 | 17% | 2% | 329 |
8 | CEA IMETI | address | 117387 | 0% | 89% | 8 |
9 | HUMAN GENE THERAPY | journal | 106886 | 8% | 4% | 148 |
10 | LENTIVIRAL TRANSGENESIS | authKW | 96041 | 0% | 73% | 8 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Medicine, Research & Experimental | 28201 | 46% | 0% | 869 |
2 | Biotechnology & Applied Microbiology | 20423 | 44% | 0% | 836 |
3 | Genetics & Heredity | 17091 | 39% | 0% | 752 |
4 | Hematology | 3992 | 14% | 0% | 276 |
5 | Virology | 3597 | 11% | 0% | 206 |
6 | Cell & Tissue Engineering | 1051 | 2% | 0% | 44 |
7 | Biochemistry & Molecular Biology | 545 | 18% | 0% | 343 |
8 | Biochemical Research Methods | 312 | 5% | 0% | 99 |
9 | Cell Biology | 174 | 7% | 0% | 133 |
10 | Immunology | 152 | 6% | 0% | 117 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EXPT HEMATOL | 248592 | 8% | 9% | 160 |
2 | U962 | 153646 | 1% | 85% | 11 |
3 | IMMUNODEFICIENCY | 123891 | 2% | 24% | 31 |
4 | CEA IMETI | 117387 | 0% | 89% | 8 |
5 | UMR S951 | 90782 | 1% | 50% | 11 |
6 | SAN RAFFAELE TELETHON GENE THER Y | 85939 | 1% | 21% | 25 |
7 | MEDAWAR | 85615 | 1% | 25% | 21 |
8 | LYMPHAT CELL THER Y | 84896 | 0% | 86% | 6 |
9 | MOL IMMUNOL UNIT | 83127 | 3% | 9% | 56 |
10 | IIT UNIT MOL NEUROSCI | 74282 | 0% | 75% | 6 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MOLECULAR THERAPY | 211400 | 11% | 6% | 217 |
2 | HUMAN GENE THERAPY | 106886 | 8% | 4% | 148 |
3 | GENE THERAPY | 87544 | 8% | 4% | 145 |
4 | HUMAN GENE THERAPY METHODS | 76653 | 2% | 16% | 29 |
5 | MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 53201 | 1% | 12% | 27 |
6 | JOURNAL OF GENE MEDICINE | 39903 | 3% | 4% | 59 |
7 | CURRENT GENE THERAPY | 39166 | 2% | 6% | 37 |
8 | HUMAN GENE THERAPY CLINICAL DEVELOPMENT | 8876 | 0% | 8% | 7 |
9 | BLOOD | 7164 | 6% | 0% | 124 |
10 | CURRENT OPINION IN MOLECULAR THERAPEUTICS | 4225 | 1% | 2% | 15 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LENTIVIRAL VECTOR | 1591450 | 16% | 31% | 311 | Search LENTIVIRAL+VECTOR | Search LENTIVIRAL+VECTOR |
2 | LENTIVIRUS | 279869 | 8% | 11% | 158 | Search LENTIVIRUS | Search LENTIVIRUS |
3 | GENE THERAPY | 120861 | 17% | 2% | 329 | Search GENE+THERAPY | Search GENE+THERAPY |
4 | LENTIVIRAL TRANSGENESIS | 96041 | 0% | 73% | 8 | Search LENTIVIRAL+TRANSGENESIS | Search LENTIVIRAL+TRANSGENESIS |
5 | INSERTIONAL MUTAGENESIS | 90498 | 2% | 13% | 43 | Search INSERTIONAL+MUTAGENESIS | Search INSERTIONAL+MUTAGENESIS |
6 | LAM PCR | 82539 | 0% | 100% | 5 | Search LAM+PCR | Search LAM+PCR |
7 | INTEGRATION SITE ANALYSIS | 68781 | 0% | 83% | 5 | Search INTEGRATION+SITE+ANALYSIS | Search INTEGRATION+SITE+ANALYSIS |
8 | LENTIVIRUS VECTOR | 62747 | 1% | 22% | 17 | Search LENTIVIRUS+VECTOR | Search LENTIVIRUS+VECTOR |
9 | PSEUDOTYPING | 62201 | 1% | 27% | 14 | Search PSEUDOTYPING | Search PSEUDOTYPING |
10 | HIV VECTOR | 58954 | 0% | 71% | 5 | Search HIV+VECTOR | Search HIV+VECTOR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |